Loss of SRY‐box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma

BACKGROUND: Oesophageal adenocarcinoma (OAC) is a highly aggressive malignancy with poor survival, which is highly variable amongst patients with comparable conventional prognosticators. Therefore molecular biomarkers are urgently needed to improve the prediction of survival in these patients. SRY (...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Br J Surg
Glavni autori: ten Kate, F. J. C., van Olphen, S. H., Bruno, M. J., Wijnhoven, B. P. L., van Lanschot, J. J. B., Looijenga, L. H. J., Fitzgerald, R. C., Biermann, K.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2017
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5600089/
https://ncbi.nlm.nih.gov/pubmed/28692180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bjs.10553
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items